BioPharma Drug Discovery
SyntheticGestalt and Enamine Partner for AI-Driven Drug Discovery Model
SyntheticGestalt, a research and development company specializing in the application of AI to the life sciences domain, and Enamine, the world's leading pr...
January 11, 2024 | News
DNAnexus and Ovation Partner to Advance Drug Discovery with Precision Health Datasets
DNAnexus, Inc., the provider of the Precision Health Data Cloud, and Ovation, an omics data company committed to accelerating the development of preci...
January 11, 2024 | News
Debiopharm and ThinkingNodeLife.ai Partner for AI-Boosted Cancer Drug Development
Debiopharm, an independent biopharmaceutical company headquartered in Switzerland, and ThinkingNodeLife.ai (TNL), a trailblazer in AI Digital Cells Lab in ...
January 10, 2024 | News
OBI Pharma's partner Biosion announces FDA clearance for the Phase 1/2 study of OBI-992 (TROP2 ADC)
First clinical trial to evaluate the safety and efficacy of OBI-992 (a.k.a BSI-992), a novel antibody drug conjugate (ADC) targeting TROP2 - Dosing of f...
January 09, 2024 | News
Novartis Partners with Isomorphic Labs to Pioneer AI-Driven Drug Discovery
Fiona H. Marshall, President of Biomedical Research at Novartis, expressed her excitement, stating, "We are entering into this collaboration with Isomorphi...
January 08, 2024 | News
Akeso's Cadonilimab Granted NMPA Acceptance for First-Line Gastric Cancer Treatment.
This will be the second indication for which cadonilimab has received approval in China, following its use as a monotherapy treatment for recurrent or...
January 08, 2024 | News
Revolutionizing Drug Discovery: 15 AI Companies to Watch in 2024
As we step into 2024, let's explore 15 AI companies at the forefront of this transformative journey. Atomwise: Revolutionizing Virtual Screening Atomw...
December 27, 2023 | News
Jemincare Announces 6 Approvals of Clinical Trials for its Innovative Drugs
On December 20, NMPA has approved a clinical trial for JMKX003801 to treat serious infection caused by Gram-negative bacteria. Drug resistance of anti...
December 27, 2023 | News
Innovent and SanegeneBio Collaborate on siRNA Drug for Hypertension Treatment
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality me...
December 27, 2023 | News
Oncoshot Collaborates with Zhejiang Ablaze for Data-Driven Drug Development in China
This collaboration brings together complementary strengths - Oncoshot's capabilities in data analysis and insights generation with Ablaze's recent expansio...
December 26, 2023 | News
Astellas Completes Acquisition of Propella Therapeutics
Through the acquisition of Propella, Astellas has acquired PRL-02 (abiraterone decanoate), a next-generation androgen biosynthesis inhibitor being develope...
December 22, 2023 | News
Juniper Therapeutics Secures Exclusive SAR Registration Rights for COVID-19 Drug from Ping An-Shionogi HK in Singapore
Singapore-headquartered Juniper Therapeutix, a science-led healthcare company focused on commercializing novel therapies, announced its agreement with...
December 22, 2023 | News
LTS Secures $4.3M Grant for Contraceptive Microneedle Array Patch Development
Poor access to contraceptives presents a significant burden for women living in LMICs. According to a 2022 study, one in 14 women worldwide who want to use...
December 20, 2023 | News
NMPA Accepts Mabwell's 8MW0511 Injection New Drug Application
8MW0511, a Class 1 therapeutic biological product, is a new generation of long-acting G-CSF (modified cytokine with high activity) with independent intelle...
December 20, 2023 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
